Article
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
The EMBO journal - 1 May 1990
Gannon J V, Greaves R, Iggo R, Lane D P
Abstract excerpt
Point mutations in the p53 gene are the most frequently identified genetic change in human cancer. They convert murine p53 from a tumour suppressor gene into a dominant transforming oncogene able to immortalize primary cells and bring about full transformation in combination with an activated ras gene. In both the human and murine systems the mutations lie in regions of p53 conserved from man to Xenopus. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
